Patents by Inventor Michael Radomsky

Michael Radomsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160279160
    Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.
    Type: Application
    Filed: June 8, 2016
    Publication date: September 29, 2016
    Applicant: DARA Biosciences, Inc.
    Inventors: Michael Radomsky, Mary Katherine Delmedico, Linda Jett
  • Publication number: 20150297721
    Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.
    Type: Application
    Filed: July 1, 2015
    Publication date: October 22, 2015
    Inventors: Michael Radomsky, Mary Katherine Delmedico, Linda Jett
  • Patent number: 9078910
    Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: July 14, 2015
    Assignee: DARA BIOSCIENCES, INC.
    Inventors: Michael Radomsky, Mary Katherine Delmedico, Linda Jett
  • Publication number: 20140045780
    Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.
    Type: Application
    Filed: August 8, 2013
    Publication date: February 13, 2014
    Applicant: DARA BioSciences, Inc.
    Inventors: Michael Radomsky, Mary Katherine Delmedico, Linda Jett
  • Publication number: 20110207666
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10?6 to 100 mg/ml.
    Type: Application
    Filed: February 9, 2011
    Publication date: August 25, 2011
    Applicant: DEPUY SPINE, INC.
    Inventor: Michael Radomsky
  • Patent number: 7902172
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1–4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10?6 to 100 mg/ml.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: March 8, 2011
    Assignee: DePuy Spine, Inc.
    Inventor: Michael Radomsky
  • Publication number: 20040176295
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10-6 to 100 mg/ml.
    Type: Application
    Filed: March 8, 2004
    Publication date: September 9, 2004
    Applicant: DePuy Acromed, Inc.
    Inventor: Michael Radomsky
  • Patent number: 6703377
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: March 9, 2004
    Assignee: DePuy Acromed, Inc.
    Inventor: Michael Radomsky
  • Patent number: 6645945
    Abstract: A composition is provided for treating diseased, injured or diseased cartilage comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site for a period of time sufficient to alleviate the symptoms of the disease, injury or abnormality. Preferably hyaluronic acid is used in a composition range of 0.01-4% by weight and the preferred growth factor is IGF-I, present in a concentration range of about 10−6 to 100 mg/ml.
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: November 11, 2003
    Assignee: DePuy Acromed, Inc.
    Inventors: Michael Radomsky, Mohammad A. Heidaran
  • Publication number: 20010014664
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.
    Type: Application
    Filed: April 3, 2001
    Publication date: August 16, 2001
    Applicant: Orquest, Inc., California Corporation
    Inventor: Michael Radomsky
  • Patent number: 6221854
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: April 24, 2001
    Assignee: Orquest, Inc.
    Inventor: Michael Radomsky
  • Patent number: 5942499
    Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10.sup.-6 to 100 mg/ml.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: August 24, 1999
    Assignee: Orquest, Inc.
    Inventor: Michael Radomsky